Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Surakit Pungpapong, M.D., studies viral hepatitis, both hepatitis B and C, and liver transplantation from the multiple viewpoints of epidemiology, natural history, diagnosis, treatment and prognosis. His research focuses include noninvasive assessment of liver fibrosis from viral hepatitis using serum markers and novel imaging technology such as magnetic resonance elastography; treatment of viral hepatitis before and after liver transplantation; impact of viral hepatitis on the outcome of liver transplantation; and how to improve the short-term and long-term outcomes of liver transplantation in patients with viral hepatitis.
The goal of Dr. Pungpapong's research is to improve the outcome of liver transplantation in patients with viral hepatitis, both hepatitis B and C. His current ongoing research evaluates the efficacy and safety of new direct-acting antiviral agents to treat hepatitis C infection before and after liver transplantation.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.